Kevin Reeves

Vice President, Sales & Marketing at Chimerix, Inc.

Kevin Reeves

Kevin Reeves

Vice President, Sales & Marketing at Chimerix, Inc.

Biography

Mr. Reeves joined Chimerix in November of 2014 and in January of 2016 was named Vice President, Sales and Marketing. He has more than twenty-eight years of pharmaceutical industry experience, with therapeutic experience spanning Antivirals (HIV, Hepatitis, and Influenza), Antibiotics (IV and oral), Respiratory (COPD and Asthma), Central Nervous System (Epilepsy, Mood Disorders, Movement Disorders, Sleep and Neuropathic Pain) and Nutritional/Metabolic Disorders. Prior to joining Chimerix, Mr. Reeves served as Executive Director of COPD Marketing for the U.S. at GlaxoSmithKline where he led prelaunch and launch activities for the company’s COPD assets, and had responsibility for therapeutic-area marketing across all COPD brands (ADVAIR, BREO, ANORO and INCRUSE). Prior to that, Mr. Reeves was Executive Director of Commercial Operations for Respiratory, Medical Center and Neurosciences at GlaxoSmithKline, where he was Chief of Staff to the Business Unit Head and led all business unit field sales and marketing operations, and field sales based Lean Sigma Teams. While at GSK, Mr. Reeves held various positions of increasing responsibility in the marketing, sales, and commercial operations functions inclusive of both specialty markets and primary care. Over his career, Mr. Reeves has launched four NCEs and four line extensions to the U.S. market. In 2007, he was recognized by DTC Perspectives as a “Top-25 DTC Marketer of the Year.” Mr. Reeves began his career in medical sales with Bristol-Myers, Mead Johnson Nutritional Divisional. He received his B.S. in Biology at Widener University in Chester, Pennsylvania.

Overview
Career Highlights

GlaxoSmithKline LLC

RelSci Relationships

382

Contact Data
Trying to get in touch with Kevin Reeves? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Kevin Reeves likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President, Clinical Pharmacology & Translational Medicine at Chimerix, Inc.

Relationship likelihood: Strong

Former Chief Commercial Officer at Chimerix, Inc.

Relationship likelihood: Average

Senior Director-Accounting at Chimerix, Inc.

Relationship likelihood: Average

Chief Science Officer at Chimerix, Inc.

Relationship likelihood: Average

Chief Medical Officer at Chimerix, Inc.

Relationship likelihood: Average

Vice President, Information Technology & Chief Information Officer at Chimerix, Inc.

Relationship likelihood: Average

Senior Vice President, General Counsel at Chimerix, Inc.

Relationship likelihood: Average

Senior Vice President, Chief Financial Officer, Principal Accounting Officer & Corporate Secretary at Chimerix, Inc.

Relationship likelihood: Average

Executive Director-IR & Corporate Communications at Chimerix, Inc.

Relationship likelihood: Average

President & Chief Executive Officer at Chimerix, Inc.

Relationship likelihood: Average

Paths to Kevin Reeves
Potential Connections via
Relationship Science
You
Kevin Reeves
Vice President, Sales & Marketing at Chimerix, Inc.
Education

Widener University is a private, coeducational university located in Chester, Pennsylvania. Founded as The Bullock School for Boys in 1821, the school was established in Wilmington, Delaware. It became the The Alsop School for Boys from 1846–1853, and then Hyatt's Select School for Boys from 1853-1859. Military instruction was introduced in 1858 and in 1859 the school changed its name to Delaware Military Academy. It moved to Pennsylvania in 1862 and became Pennsylvania Military Academy. It was known as Pennsylvania Military College after 1892 and adopted the Widener name in 1972.

Career History
Vice President, Sales & Marketing
2014 - Current

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Based on proprietary lipid conjugate technology, the company's two clinical stage compounds have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. CMX001 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofovir-diphosphate. Its broad spectrum activity against double-stranded DNA (dsDNA) viruses without the myelotoxicity and nephrotoxicity of current agents has the potential to improve outcomes for immunosuppressed patients. Chimerix's second clinical-stage antiviral compound, CMX157 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent tenofovir-diphosphate. It has the potential to directly address several limitations of current HIV and HBV therapies. Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, influenza, malaria and other global public health needs.

Executive Director-Copd Marketing
Prior

Smithkline Beecham Corp. engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products for customers in the United States. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. The company also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Other Affiliations

Kevin Reeves is affiliated with Chimerix, Inc., GlaxoSmithKline LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kevin Reeves. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kevin Reeves's profile does not indicate a business or promotional relationship of any kind between RelSci and Kevin Reeves.